UNIVERSITY OF WASHINGTON
MATCHMAKERS
MATCHMAKERS is a funding opportunity from UNIVERSITY OF WASHINGTON, up to 497367, closing April 30, 2027.
Apr 30, 2027
(273d left)Overview
Abstract Understanding how T cell receptors (TCRs) see tumor antigens presented by MHCs is necessary to fully understand how the immune system recognizes tumor antigens, and to reap the full potential of antigen-specific immunotherapy. To achieve this goal, a quantum leap forward is required in which the revolutionary…